Invivyd

IVVDNasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$300.654 M

$1.02 +35.05%

Close of 21 Sept 2026

Revenue

$53.4M

#2709 by revenue

Earnings

-$52.5M

Loss-making

Shares outstanding

294,758,746

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 160 →

#85Inhibikase TherapeuticsIKT$307.0M
#86Fate TherapeuticsFATE$303.1M
#87InvivydIVVD$300.7M
#88Palisade BioPALI$294.5M
#89Sutro BiopharmaSTRO$271.1M

What if Invivyd were worth as much as…

Open the what-if tool →

Gold $30.3T

$102,707.91

Per share 100,694× higher

Bitcoin $1.72T

$5,834.61

Per share 5,720× higher

Nvidia $5.48T

$18,590.99

Per share 18,226× higher

Or at a round number

$500.0M $1.00B $2.00B $5.00B

Where these numbers come from

Share counts and financials for Invivyd are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.